Skip to content

Focused Manual Ingest Batch 5

Scope

This audit records a private-wiki source-review pass completed on 2026-04-29.

The pass deep-ingested one newly added RAW PDF and nine previously provisional source notes. The purpose was to strengthen the ILC2/ILC3 lung disease wiki around severe-asthma sputum ILC2/ILC3 boundary states, ILC2 restraint mechanisms, pulmonary ILC3 tuberculosis defense, and review-level asthma or infection orientation.

Sources Promoted

Knowledge-Layer Changes

  • Added human severe-asthma sputum evidence for c-kit+ IL-17A+ intermediate ILC2s and ILC3/neutrophilia, with a strict sputum/airway compartment boundary.
  • Added hUC-MSC and vitamin D3/Blimp-1/IL-10 restraint branches for ILC2 asthma output, while preserving non-ILC2-exclusive caveats.
  • Added Mtb/tuberculosis as a protective pulmonary ILC3 infection branch.
  • Added current and older review sources as orientation layers rather than primary mechanistic anchors.

Interpretation Limits

  • Review pages promoted in this pass remain review-level evidence and should route readers toward primary sources.
  • Human sputum data are not treated as lung parenchymal lineage tracing.
  • Therapeutic language remains mechanistic or hypothesis-level unless supported by direct intervention evidence.